Part II: Receptors, Ion Channels and Signalling Flashcards
What are GPCR involved in
Senses, autonomic function
GPCR structure
Single polypeptide in an anticlockwise bundle, 7 (α-helices) transmembrane spanning domains, extracellular N terminus, intracellular C terminus and 3 extra (ECL) and intracellular loops (ICL)
Another name for GPCR
7 transmembrane domain receptors
5 families of GPCR and info abt them
1) Family A “Rhodopsin” = most common. 2) Family B “Secretin”: Some peptide hormones. 3) Family C “Glutamate”: Glutamate + GABA neurotrans in brain. Calcium + some taste receptors. 4) “Frizzled”: Receptors in development, bitter taste receptors. 5) “Adhesion”: Cell-cell adhesion and motility
How does the rhodopsin (A) family bind ligands
Mostly small molecs: Binding site within transmembrane domain bundle. Medium sized ligand sites involve bundle and receptor ECL domains + N terminus. Largest = N-terminus built to generate a binding site
How does Glutamate (C) family bind to ligands
To small molecules but have a large N terminus called Venus Fly Trap (VFT) domain. It closes around the ligand to activate the recptor.
Types of bonds on binding site
Ionic: +ve charge NH3+ with COO- amino acid, Hydrogen bonds, Hydrophobic bonds with benzene rings
What is receptor mutagenesis
Change amino acid you think is important on binding site by genetic engineering. Eg change OH group to CH3. Then run competition binding study to find if it made a difference.
How can GPCR structures be seen/visualised
X ray crystallography
What is an allosteric modulator
Binds to a separate site from agonist orthosteric site. Changes nature of response to orthosteric agonist. Can alter orthosteric ligands affinity (ability to bind) / acitvate receptor/both
What are positive/negative allosteric modulators
Positive: enhances agonist effect. Negative: inhibits agonist effect
What is co-operativity for allosteric modulators
Orthosteric + allosteric ligands influence each other. Positive coop for PAMs (ennhances agonist effect) + negative for NAMs
How can an allosteric modulator prevent the dissociation of agonist
Bind above binding bocket so its locked in. Enhances the affinity
Benefits of allosteric modulation
Increased selectivity: Agonist needs to be present otherwise no effect. Allosteric sites may be unique to receptor subtype. Controlled response: Max effect is limited. Reduces risk of receptor over stimulation
Conformational change of GPCR during activation of drug+receptor
Extracellular domain with drug moves inward. Intracellular moves away from each other allowing effectors such as G proteins to be recruited
What are heterotrimeric G proteins
GPCRs activate them. G proteins made of 3 subunits where at least 1 is different from the other 2
What are the G protein subunits
Gα: Binds guanine nucleotides (GDP/GTP). Gβ + Gγ: Always form a dimer (Gβγ)
Where are Gα and Gβγ located
On intracellular side of plasma membrane (using lipid anchors)
What is the G protein cycle
1) When GPCR inactive, Gα binds GTP and forms a heterotrimeric complex with Gβγ. 2) Activated GPCR catalyses exchange of GDP for GTP on Gα by conformational change. 3) Gα-GTP & Gβγ separate from each other. 4) Gα-GTP & Gβγ activate effector proteins along membrane. 5) GTPase activity of Gα converts bount GTP back to GDP. 5) Gα-GDP reassociates with Gβγ.
3 main Gα classes
Gsα: stimulates adenylyl cyclase whcih increases cyclic AMP. Giα: inhibits adenylyl cylcase - decreases cyclic AMP eg smooth muscle contaction, inhibits transmitter release. Gqα: stimulates phospholipase C - enhanced transmitter release, increases intracellular Ca2+, smooth muscle contraction
ATP -> cAMP -> response -> break down cycle
ATP + adenylyl cyclase enzyme -> cAMP. Protein kinase A (PK A) forms an inactive tetramer of 2 regulatory + 2 catalytic subunits. cAMP binds to regulatory -> dissociates tetramer, releases active catalytic subunits. PK A phosphorylates target protein -> response. cAMP broken down by phosphodiesterase -> AMP -> ATP
cAMP pathway in Gs coupled receptors
Gsα-GTP releases from acitvated receptor. Activates adenylyl cyclase which generates cAMP from ATP. cAMP binds to regulatory subunits on Portein kinase A which releases activates catalytic. They phosphorylate target proteins
cAMP pathway in Gi coupled receptors
ATP is stopped from converting to cAMP bc adenylyl cyclase is inhibited
Calcium pathway by Gq couple receptors
Gqα-GTP activates phospholipase C (PL C) enzyme. This hydrolyses plasma membrane lipid (PIP2). This releases 2 intracellular messengers: IP3 = diffusable out into cytoplasm & DAG = fatty acid tails kept in membrane. IP3 releases Ca2+ from intracellular stores in endoplasmic reticulum into cytoplasm. DAG activates protein kinase C (PK C) which goes to own target for phosphorylation.